Calgary (Rajeev Sharma): Alberta is strengthening its cancer-care capabilities with a new radiopharmaceutical facility in Calgary, expanding the province’s ability to produce essential radioisotopes used in advanced cancer treatments.
The facility is designed to address major transportation challenges associated with specialized radiopharmaceutical therapies. By producing critical radioisotopes closer to patients and treatment centres, the initiative is expected to help reduce logistical barriers and bring advanced cancer care closer to Albertans.
Radiopharmaceuticals use radioactive substances to target cancer cells and are an increasingly important part of modern cancer treatment. Because some of the radioisotopes used in these therapies have short lifespans, local production can play a crucial role in ensuring timely and reliable access.
The Calgary facility marks an important step in strengthening Alberta’s health-care infrastructure and expanding access to specialized cancer treatments.
For patients and their families, the development could mean fewer transportation barriers, improved access to treatment and advanced cancer care closer to home.
